Clinical Research News
Search and Filter
Results per Page:
Leader in apheresis and cellular therapy, Dr. Michael Linenberger, retires
As professor emeritus, this respected mentor will continue to contribute to the UW fellowship program
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Fred Hutch/UW/Seattle Children’s Cancer Consortium breast cancer researchers receive grants
Breast Cancer Research Foundation supports projects including new imaging tracer, better risk prediction for luminal B subtypes, anti-inflammatory vaccine and more
New approach could make bone marrow transplantation safer, stronger
Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma
Hutch scientists receive $25M to solve breast cancer metastasis
New collaboration will target dormant tumor cells, keeping them asleep (or killing them) so they won’t spread
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Dr. Brenda Sandmaier named president of American Society for Transplantation and Cellular Therapy
Transplant immunotherapy physician-scientist will serve 2022-2023 term
How zinc boosts the immune system
In mice, mineral improves regeneration of key immune organ and immune-cell recovery after bone marrow transplant
Science Says: Comedian, researchers tackle tough topics
Trevor Noah and scientists discuss colorectal cancer screening, community involvement in research, science communication
Dr. Michael Linenberger honored for contributions to apheresis medicine
Presidential Award from American Society for Apheresis recognizes hematologist’s two decades of service
How does leukemia escape from immunotherapy?
Single-cell sequencing tech enables deep dive into mysterious results, sets stage for future improvements
Dr. Rachel Issaka receives the Kathryn Surace-Smith Endowed Chair in Health Equity Research
Flexible funding will further physician-scientist’s work in colorectal cancer and health inequities
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Science Says: Fearless science
Immunotherapy, equity in colorectal cancer and the latest on the COVID-19 virus's omicron variant
Toward better cures for kids with AML: Q&A with Dr. Soheil Meshinchi
How researchers are developing personalized therapies for the deadliest childhood leukemia that have fewer side effects
Science Says: Cracking the code in solid tumors
How scientists are developing targeted new therapies for cancers of the breast, lung, stomach and more
Q&A: Returning to school, post-transplant
As schools reopen for in-person learning, what should bone marrow transplant recipients do?
Fred Hutch mourns sudden loss of Dr. Martin ‘Mac’ Cheever
A long career devoted to bringing immunotherapies from bench to bedside
Ongoing trials test COVID-19 drugs for earlier, easier treatment
Injected monoclonal antibodies or oral antivirals could help more patients recover faster
Investment in business development pays dividends for research, patients
Fred Hutch tech transfer specialists help scientists navigate path to bringing innovations to patients